Antoine Pouppez co-founded neuroClues six years ago. Today it's raised over £25M and employs 40+ people across Belgium and France, building MedTech that treats neurological disorders through eye tracking.

His approach from day one: if it's core to the product, you build it yourself, no matter how much longer or more expensive that is. James and Antoine get into why that decision holds up outside MedTech too, how he kept investors on side through a year long delay, and the one question that decides what's worth doing properly versus what can wait.

More from James:

Connect with James on LinkedIn or at peer-effect.com